Registration for Cancer Crosslinks 2022 is open. Cancer Crosslinks 2022 will be streamed on Thursday, 27 January 2022, from 12:00 to 16:15 CET from Oslo Cancer Cluster Innovation Park.
We plan for a Digital Meeting with the option to attend on-site (pending COVID-19 guidelines). The scientific program will be complemented with networking for on-site participants from 16:15 CET.
Please see this Cancer Crosslinks website for information about the speakers and the programme.
Registration is open
Please register for the event at the bottom of this page. If you intend to attend physically, please only check the one box saying “on-site”.
Spaces will be available for participants to join “on-site” pending COVID-related guidelines. The organizers will send confirmations to all registrants to confirm on-site attendance with the networking session in December 2021. The link to the digital event will be sent to all registrants one week prior to the event.
Please note: For industry participants, a maximum of two representatives are invited to register for the on-site event.
About Cancer Crosslinks
Cancer Crosslinks is an educational meeting series which promotes interactions between researchers and clinicians, and encourages translational and clinical research to support collaborations to advance the development of innovative cancer treatments.
Established in 2009 by Oslo Cancer Cluster in collaboration with its member, Bristol Myers Squibb, this yearly meeting has become a leading forum gathering oncologists, hematologists, translational researchers, healthcare providers, regulatory experts, and industry representatives.
The hallmark of Cancer Crosslinks is the educational program featuring international and Norwegian experts presenting recent advances in oncology. The educational program is complemented by tailored activities to stimulate additional interactions and discussions between speakers and representatives from the oncology community.
Cancer Crosslinks 2022 is sponsored by BMS and GSK